Results 111 to 120 of about 18,529 (289)

Inducing emesis in Australian dogs and cats: agents, adverse effects and antiemetic administration

open access: yesAustralian Veterinary Journal, Volume 103, Issue 7, Page 433-442, July 2025.
Objective To describe the agents used by Australian veterinarians in inducing emesis in dogs and cats, adverse effects and antiemetic administration. Methods An anonymous online mixed‐methods survey incorporating closed and open‐ended questions was distributed to Australian veterinarians via e‐newsletters and social media between April and June 2024 ...
J Tsitonakis, E Hall, A Quain
wiley   +1 more source

Haematological and infectious complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease [PDF]

open access: yes, 2017
A complication is an event or occurrence that is associated with a disease or a healthcare intervention, is a departure from the desired course of events, and may cause, or be associated with, suboptimal outcome.
Bronicki, Ronald   +5 more
core  

Antifibrinolytic therapy to reduce haemoptysis from any cause.

open access: yesCochrane Database of Systematic Reviews, 2016
BACKGROUND Haemoptysis is a common pathology around the world, occurring with more frequency in low-income countries. It has different etiologies, many of which have infectious characteristics. Antifibrinolytic agents are commonly used to manage bleeding
Gabriela J. Prutsky   +3 more
semanticscholar   +1 more source

Dental extraction in patients rece iving dual antiplatelet therapy [PDF]

open access: yes, 2015
Background: Dual antiplatelet therapy consists of administering antiplatelet (antiaggregant) drugs (clopidogrel and aspirin) to prevent thrombotic processes, as a preventative measure in patients with acute coronary disease, or in patients ...
Calvo Guirado, José Luis   +7 more
core   +2 more sources

A prospective non‐inferiority trial of pathogen reduced platelets compared to non‐pathogen reduced platelets for correction of viscoelastic platelet function testing in cardiac surgery

open access: yesTransfusion, Volume 65, Issue 7, Page 1293-1306, July 2025.
Abstract Background Cardiac surgery on cardiopulmonary bypass (CPB) may alter platelet (PLT) function causing bleeding. The goal of this study is to evaluate the hemostatic effect of PRT‐PLTs compared to untreated PLTs stored in platelet additive solution (PAS) following transfusion in bleeding patients undergoing cardiac surgery on CPB.
Magali J. Fontaine   +11 more
wiley   +1 more source

Seizure induced by tranexamic acid in a patient with chronic kidney disease on maintenance dialysis

open access: yesSaudi Journal of Kidney Diseases and Transplantation, 2018
Tranexamic acid (TXA) is an antifibrinolytic agent commonly used to achieve hemostasis. However, there have been a few case reports suggesting that high-dose intravenous TXA has epileptogenic property.
Kar Wah Fuah   +3 more
doaj   +1 more source

Acute lower limb ischemia due to thrombo-embolic arterial occlusions in two previously healthy men with markedly elevated Lp(a) [PDF]

open access: yes, 2006
Lipoprotein (a) (Lp(a)) is a well-documented risk factor for atherosclerotic cardiovascular disease. Its role in acute thrombo-embolic occlusions of peripheral arteries is not known.
Federico Tatò   +6 more
core   +3 more sources

Lipoprotein(a) levels in Down syndrome: A conundrum

open access: yesAlzheimer's &Dementia, Volume 21, Issue 6, June 2025.
Abstract INTRODUCTION Lipoprotein a (Lp(a)) is a low‐density lipoprotein (LDL)‐like particle that has been associated with risk for vascular inflammation, atherogenesis, calcification, and thrombosis in the general population but is also a risk factor for Alzheimer disease (AD).
Herminia Diana Rosas   +2 more
wiley   +1 more source

Perioperative hyperfibrinolysis – physiology and pathophysiology

open access: yesBrazilian Journal of Anesthesiology, 2021
Introduction and objectives: The role of the anesthesiologist in the perioperative management of hemostasis has attracted increasing attention. The fibrinolytic system participates in hemostasis, removing clots after repair of the vascular injury.
David Silveira Marinho
doaj  

Antifibrinolytic agents in current anaesthetic practice.

open access: yesBritish Journal of Anaesthesia, 2013
Antifibrinolytic drugs have become almost ubiquitous in their use during major surgery when bleeding is expected or commonplace. Inhibition of the fibrinolytic pathway after tissue injury has been consistently shown to reduce postoperative or traumatic ...
E. Ortmann, M. Besser, A. Klein
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy